Healthcare entrepreneur and investor, having founded several biotech companies, nanotech companies, and venture capital / PE funds. Current companies include Sensulin, which is developing a next-generation insulin for diabetes. Formerly: Co-Founder and Chief Executive Officer, an ocular pharmaceutical company and specialty Contract Research Organization (eyeCRO), which was the 264th fastest growing private company in the 2009 Inc. 500; co-founded Nanopolaris (now Unidym), which was acquired in 2011 by a publicly traded South Korean company for $145 million; co-founded NanoSource, which was acquired by DuPont in 2002, largely considered the first major acquisition in the nanotech space. 2017 Young Global Leader, World Economic Forum.